North America clinical trials market is projected to grow by 7.1% annually in the forecast period and reach $39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
Highlighted with 89 tables and 75 figures, this 178-page report "North America Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire North America clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.
Based on Product Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Trials of Drugs
o Small Molecule Drugs
o Vaccines
o Cell & Gene Therapy
o Other Drugs
• Trials of Devices
• Trials of Procedures
Based on Phase, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Phase I
• Phase II
• Phase III
• Phase IV
By Design, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Interventional Studies
o Randomized Control Trial
o Adaptive Clinical Trial
o Non-randomized Control Trial
• Observational Studies
o Cohort Study
o Case Control Study
o Cross Sectional Study
o Ecological Study
• Expanded Access Trials
By Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Clinical Trial Supply & Logistic Services
• Decentralized Clinical Trial Services
• Medical Device Testing Services
• Other Clinical Trial Services
By Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Oncology
• Infectious Diseases
• Cardiology
• Obesity
• Diabetes
• Neurology
• Immunology
• Pain Management
• Other Indications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pharmaceutical and Biotechnological Companies
• Clinical Research Organizations
• Clinical Testing Laboratories
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of each national market by Phase, Design, and Indication over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PhlexNorth America
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 28
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 39
2.4 Emerging Opportunities and Market Trends 42
2.5 Porter's Fiver Forces Analysis 46
3 Segmentation of North America Market by Product Category 50
3.1 Market Overview by Product Category 50
3.2 Trials of Drugs 52
3.2.1 Small Molecule Drugs 53
3.2.2 Vaccines 54
3.2.3 Cell & Gene Therapy 55
3.2.4 Other Drugs 56
3.3 Trials of Devices 57
3.4 Trials of Procedures 58
4 Segmentation of North America Market by Phase 59
4.1 Market Overview by Phase 59
4.2 Phase I 61
4.3 Phase II 62
4.4 Phase III 63
4.5 Phase IV 64
5 Segmentation of North America Market by Design 65
5.1 Market Overview by Design 65
5.2 Interventional Studies 67
5.2.1 Randomized Control Trial 69
5.2.2 Adaptive Clinical Trial 70
5.2.3 Non-randomized Control Trial 71
5.3 Observational Studies 72
5.3.1 Cohort Study 74
5.3.2 Case Control Study 75
5.3.3 Cross Sectional Study 76
5.3.4 Ecological Study 77
5.4 Expanded Access Trials 78
6 Segmentation of North America Market by Service Type 79
6.1 Market Overview by Service Type 79
6.2 Protocol Designing 81
6.3 Site Identification 82
6.4 Patient Recruitment 83
6.5 Laboratory Services 84
6.6 Bioanalytical Testing Services 85
6.7 Clinical Trial Data Management Services 86
6.8 Clinical Trial Supply & Logistic Services 87
6.9 Decentralized Clinical Trial Services 88
6.10 Medical Device Testing Services 89
6.11 Other Clinical Trial Services 90
7 Segmentation of North America Market by Indication 91
7.1 Market Overview by Indication 91
7.2 Oncology 93
7.3 Infectious Diseases 94
7.4 Cardiology 95
7.5 Obesity 96
7.6 Diabetes 97
7.7 Neurology 98
7.8 Immunology 99
7.9 Pain Management 100
7.10 Other Indications 101
8 Segmentation of North America Market by End User 102
8.1 Market Overview by End User 102
8.2 Pharmaceutical and Biotechnological Companies 104
8.3 Clinical Research Organizations 105
8.4 Clinical Testing Laboratories 106
8.5 Other End Users 107
9 North America Market 2021-2031 by Country 108
9.1 Overview of North America Market 108
9.2 U.S. 111
9.3 Canada 114
9.4 Mexico 116
10 Competitive Landscape 118
10.1 Overview of Key Vendors 118
10.2 New Product Launch, Partnership, Investment, and M&A 122
10.3 Company Profiles 123
Accell Clinical Research LLC 123
Charles River Laboratories 125
ClinDatrix Inc 128
Clinipace 129
Eli Lilly and Company 131
F. Hoffmann-La Roche Ltd. 134
ICON PLC 137
IQVIA Holdings, Inc. 140
Laboratory Corporation of America (Covance Inc.) 144
Novo Nordisk AS 148
PAREXEL International Corporation 151
Pfizer Inc. 155
Pharmaceutical Product Development LLC 160
Phlexglobal 163
PRA Health Sciences 165
Sanofi SA 167
SGS SA (SGS Life Sciences) 170
Syneos Health Inc. 173
Wuxi AppTec Inc. 176
RELATED REPORTS 178
The Clinical Trial Simulation Tools Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Cloud Computing in Clinical Trials Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
Market Overview
The North America Vanadium Market is expected to experience substantial growth from 2024 to 2034, driven by increasing demand from various sectors such as iron and steel, energy storage, and chemicals. The market is projected to grow from USD XXX.XX million in 2024 to US...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The North America Anti-Pollution Mask Market is anticipated to witness significant growth from 2024 to 2034, driven by increasing awareness of air quality issues and the rising prevalence of respiratory diseases. The market, encompassing a wide range of anti-pollution ma...
Market Overview
The North America Ethnic Wear Market is set to experience considerable growth from 2024 to 2034, driven by evolving fashion trends and a growing appreciation for cultural heritage. The market, which includes a diverse range of ethnic apparel, is projected to reach USD XX...
Market Overview
The North America FinTech Investment Market is set to experience substantial growth from 2024 to 2034, driven by an accelerated adoption of innovative financial technologies across various sectors. The market, which encompasses investments in a wide range of FinTech solu...
Market Overview
The North America Airport Asset Tracking Market is set for significant growth from 2024 to 2034, driven by advancements in asset tracking technologies and increased focus on operational efficiency and safety within airport environments. The market is projected to grow fr...
Market Overview
The North America Sustainable Aviation Fuel Market is projected to experience robust growth from 2024 to 2034, driven by increasing environmental regulations, rising focus on reducing carbon emissions in aviation, and advancements in alternative fuel technologies. By 203...